Partners

Pint of Science Pint of Science
Pint of Science is an annual science festival that aims to communicate contemporary scientific developments to the public in an informal and relaxed atmosphere of pubs and cafés. This festival takes place during the month of may and brings together 14 000 people in France and 150 000 people worldwide (400 cities in 29 countries). Scientists taking part in this festival narrate stories from their research field and their latest findings, aimed at feeding societal debates fuelled by science. In such an environment science is perceived in its true nature: full of interactions, curiosity and simplicity; all of that while creating a place open for discussions, questions and open dialogs with the public coming together in an informal atmosphere with a drink in your hand.
ROCHE ROCHE
"Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose, and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials, and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognized as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. In 2019, Roche invested CHF 11.7 billion in R&D and posted sales of CHF 61.5 billion. Genentech, in the United States, is a wholly-owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com."
ADOC talent management ADOC talent management
"Founded in 2008, Adoc Talent Management is the first firm specializing in career management focused on research personnel and graduates from all disciplines. From the very beginning, the Adoc team has been rooted in the innovation ecosystem, driven to promote the competencies of PhDs. They provide recruitment and consulting services to companies, public sector organizations, and associations, providing them with an in-depth understanding of the expectations of both recruiters and PhDs. Their R&D department conducts studies on the skills and employability of PhDs and develops career guidance tools and skill frameworks. Adoc offers services and projects of the highest quality, anchored in the reality of the job market."
ABG ABG
"A French association designed to prepare and help PhD graduates to pursue a career in business. It offers training courses for doctoral and PhD students and has a job site for the dissemination and consultation of job offers, PhD and Master 2 subjects, as well as a CV library of candidates from all scientific disciplines. They help also companies to hire Doctors."
APEC APEC
"A French association, private and joint, financed by the contributions of executives and private sector companies, whose objective is to provide service and advice to companies, executives and to young graduates of higher education on subjects relating to their employment. It offers companies services to optimize their recruitment and internal skills management. As an observatory of the executive job market, Apec provides analysis and benchmarks on major trends."
CAPE CAPE
"The Commission d'Aide aux Projets Etudiants (CAPE) brings together the FSDIE Commission of the University of Strasbourg and the Commission Culture-ActionS of Crous. The main objectives of CAPE are: - to simplify the financing procedures for students with projects - to allow a better readability for the funders on the projects presented - create a new dynamic and thus encourage student initiatives"
Domain Therapeutics Domain Therapeutics
"Domain Therapeutics is a biopharmaceutical company dedicated to the discovery and early development of new drug candidates targeting transmembrane receptors, in particular, G Protein-Coupled Receptors (GPCRs), one of the most important classes of drug targets. Domain identifies and develops candidates (allosteric modulators and biased ligands) through its innovative approach and technologies. Domain has three revenue-generating pillars within its innovative business model: 1) collaboration with pharma companies for the discovery of new molecules 2) out-licensing of its bioSens-All™ technology and 3) creation of asset-centric vehicles for the development of its internal pipeline of preclinical candidates for central nervous system disorders, cancer and rare diseases. These asset-centric companies attract investment for focused development and exit is through a trade sale at an appropriate inflection point."
Hello Tomorrow Hello Tomorrow
"Hello Tomorrow Global Summit is an unmissable event for Deeptechs in Europe. They power startup competitions worldwide to give innovation a platform by partnering with 250+ universities & accelerators. This global platform provides the participants with an unparalleled opportunity to take part in interactive sessions to improve their business skills and meet the best deep-tech startups, one of the key players shaping tomorrow’s world. Join them to unlock the power of deep technologies in solving the toughest global challenges. Visit the website to learn more https://hello-tomorrow.org/summit"
IGBMC IGBMC
"IGBMC resulted from the fusion of two Strasbourg laboratories, the Laboratory of Molecular Genetics of Eukaryotes (LGME) and the Structural Biology Laboratory, led respectively by Pierre Chambon and Dino Moras. Since its inauguration in 1994, researchers at the IGBMC are recognized for their excellence among the international scientific community. The domains of the investigation carried out at the Institute ranges from developmental biology to integrative structural biology via functional genomics, cancer, translational medicine, and neurogenetics."
La Gazette du Laboratoire La Gazette du Laboratoire
"La Gazette du LABORATOIRE is a platform to gather and discuss. It is accessible to all individuals coming from the laboratory and more broadly from the scientific world. Created by a scientist for scientists, La Gazette du LABORATOIRE follows the life of french-speaking laboratories doing research, development, analysis, and regulation since 1995. Discover more information on their France edition, Africa edition, and the following websites www.gazettelabo.fr and www.LABORATOIRE.com: - Specific articles and content - Resources for your everyday work - Technical and practical advice - Business testimonies, training and job ads - Information about laboratory and science-related events - Tools to communicate on your news, your projects and to increase your visibility - A search engine dedicated to services and equipment for laboratory and the scientific field. La gazette du LABORATOIRE provides you with a team listening to any question that you would want to address: contact us or call us at +33(0)4 77 72 09 65"
WoodLight WoodLight
"WoodLight was co-founded in July 2018 by an alsatian biologist couple, Rose-Marie & Ghislain Auclair. They both are passionate about Biology and very sensitive to Ecology and its current problems. Their ambition is to address the actual problems of cities with overconsumption of energy, pollution, and lack of greenery. For that, they have developed bioluminescent plants. These plants are able to emit light by themselves without consuming electricity. Such lamps will be 100% recyclable and depolluting the air, owing to their capacity to fix CO2 levels. Since we can develop potentially all type of bioluminescent plants, the design and so the applications of this are infinite. WoodLight wishes to make our cities greener while providing a solution to environmental problems such as pollution, overconsumption of energy, and the decline in green spaces. This new source of light will bring the cities to life and will rescue the symbiotic relationship between humans and nature."
Online user: 17 Privacy
Loading...